CORCEPT THERAPEUTICS INC's ticker is CORT and the CUSIP is 218352102. A total of 233 filers reported holding CORCEPT THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is 0.94 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $11,661 | -15.7% | 428 | -31.2% | 0.00% | – |
Q2 2023 | $13,840 | +23.4% | 622 | +20.1% | 0.00% | – |
Q1 2023 | $11,220 | +83.5% | 518 | +72.1% | 0.00% | – |
Q4 2022 | $6,114 | +1.9% | 301 | +25.9% | 0.00% | – |
Q3 2022 | $6,000 | +200.0% | 239 | +121.3% | 0.00% | – |
Q2 2022 | $2,000 | +100.0% | 108 | +56.5% | 0.00% | – |
Q1 2022 | $1,000 | -50.0% | 69 | -14.8% | 0.00% | – |
Q1 2021 | $2,000 | -33.3% | 81 | -52.9% | 0.00% | – |
Q3 2020 | $3,000 | -50.0% | 172 | -51.0% | 0.00% | – |
Q2 2020 | $6,000 | +200.0% | 351 | +96.1% | 0.00% | – |
Q1 2020 | $2,000 | 0.0% | 179 | 0.0% | 0.00% | – |
Q4 2019 | $2,000 | -33.3% | 179 | 0.0% | 0.00% | – |
Q3 2019 | $3,000 | +50.0% | 179 | 0.0% | 0.00% | – |
Q2 2019 | $2,000 | -33.3% | 179 | -4.8% | 0.00% | – |
Q4 2018 | $3,000 | +200.0% | 188 | +111.2% | 0.00% | – |
Q3 2018 | $1,000 | -98.7% | 89 | -98.1% | 0.00% | – |
Q1 2018 | $76,000 | -35.0% | 4,648 | -28.5% | 0.00% | – |
Q4 2017 | $117,000 | -4.9% | 6,499 | +2.2% | 0.00% | – |
Q3 2017 | $123,000 | +515.0% | 6,357 | +272.0% | 0.00% | – |
Q2 2017 | $20,000 | – | 1,709 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
INGALLS & SNYDER LLC | 8,370,017 | $181,295 | 9.31% |
Novo Holdings A/S | 3,377,768 | $73,162,455 | 4.83% |
Parallel Advisors, LLC | 3,724,573 | $80,674,251 | 2.72% |
TANAKA CAPITAL MANAGEMENT INC | 35,539 | $770 | 2.24% |
Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
Shay Capital LLC | 350,000 | $7,581,000 | 1.49% |
S&T BANK/PA | 350,924 | $7,601 | 1.37% |
Birchview Capital, LP | 50,000 | $1,083 | 0.85% |
Clearview Wealth Advisors LLC | 34,275 | $742,397 | 0.75% |
Granite Investment Partners, LLC | 795,076 | $17,221,346 | 0.72% |